TSMC's strong fundamentals contrasted with market overreaction
TSMC reported robust margins and issued strong guidance. The article argues the market's reaction is excessive.
Why it matters: This RSS-imported item awaits further analysis on market impact.
Chip Stock Selloff Deepens in Asia as TSMC Fails to Impress
Asian chip stocks tumbled more than 5%, with TSMC shares falling up to 4.5% in Taipei despite the company raising its 2026 capex guidance to $60-64 billion, as investors grew fatigued from the yearslong AI boom and concerned about rising equipment costs squeezing margins. A Bloomberg index of Asian chip stocks dropped roughly 19% from its June peak, with analysts noting that stretched valuations—TSMC trades at ~20x forward earnings versus a 5-year average of 18x—suggest sentiment is shifting toward rotation into other sectors.
Why it matters: Even TSMC's suppliers including Japan's Lasertec and Taiwan's Globalwafers fell on the results, while Morgan Stanley attributed the extra capex partly to equipment price inflation, adding disappointment over margin impact.
UnitedHealth rallies premarket while chip stocks retreat; TSMC's record earnings
UnitedHealth Group surged 7.6% after reporting adjusted EPS of $6.38, well above estimates, with revenue also beating forecasts amid strength across its healthcare businesses. TSMC posted record Q2 profit up 77% year-on-year with EPS of $4.31 vs $3.80 estimates, but shares fell ~4% on concerns over an expanded capex plan and near-term margin pressure, dragging chip stocks lower.
Why it matters: Nvidia slipped 1.3%, AMD fell 3.4%, and Intel and Micron dropped 1.9-2.7% as investors assessed higher industry investment spending, while psychedelic drug developers rallied on Eli Lilly's acquisition of AtaiBeckley.
TSMC posts record profit; markets await retail sales and earnings data
TSMC achieved a record profit, according to the report. Market attention is now turning to upcoming retail sales and earnings figures.
Why it matters: The story is covered by Yahoo Finance as part of what's moving markets.
TSMC Q2 Profit Jumps 77% to Record, Far Surpasses Expectations
TSMC reported a 77% year-over-year surge in second-quarter net profit to T$706.6 billion ($21.99 billion), driven by surging global demand for AI processors. The result handily beat the LSEG SmartEstimate consensus of T$632.6 billion, marking the company's continued streak of record earnings.
Why it matters: Key customers including Nvidia and Apple are the primary drivers of demand for TSMC's advanced AI chip manufacturing services.
TSMC Posts 77% Profit Jump in Q2, Far Surpassing Market Expectations
TSMC reported a record Q2 profit of T$706.6 billion ($21.99 billion), a 77% year-over-year jump that significantly exceeded the T$632.6 billion analyst forecast, marking its ninth consecutive quarter of double-digit profit growth. Surging demand for 3nm and 2nm AI chips and advanced CoWoS packaging technology drove Q2 revenue up 36% to a record high, pushing TSMC's market cap to ~$1.97 trillion—nearly double that of Samsung.
Why it matters: Analysts expect TSMC to raise its full-year revenue growth outlook and potentially increase capital spending during its earnings call, with 2026 capex already guided at the high end of $52-56 billion amid a $165 billion Arizona fab investment.
Dow rises, S&P 500 and Nasdaq fall as chip stocks slide amid AI jitters
The Dow rose while the S&P 500 and Nasdaq fell as chip stocks weakened amid AI-related concerns. TSMC remained in focus as semiconductor shares faced pressure.
Why it matters: Earnings reports and economic data were also in the spotlight for investors.
TSMC Q2 Earnings Review: Juggernaut Continues Unstoppable Growth
TSMC's Q2 earnings review highlights the company's relentless growth trajectory. The analysis underscores TSMC's dominant position in the semiconductor industry.
Why it matters: No stopping the juggernaut as TSMC maintains strong performance.
Premarket Movers: UnitedHealth, TSMC, GE Aerospace, and J.B. Hunt
CNBC reported on stocks making the biggest moves in premarket trading. Notable companies include UnitedHealth, TSMC, GE Aerospace, and J.B. Hunt.
Why it matters: The article is sourced from an RSS feed and awaits further analysis.
TSMC Stock Slides Despite Crushing Q2 Estimates With Fifth Straight Record Profit
TSMC reported Q2 net income of NT$706.56 billion ($22 billion), up 77.4% year-over-year and well above the NT$632.64 billion consensus estimate, marking its fifth consecutive quarter of record profit. Revenue reached NT$1.27 trillion ($39.45 billion), up 36% from last year's NT$933.79 billion, with advanced 7nm-and-below technologies accounting for 77% of total wafer revenue driven by AI demand from Nvidia, Apple, and Broadcom.
Why it matters: Despite the results, TSMC shares fell 3.76% to $403.71 in premarket trading; the company forecast Q3 revenue of $44.6-$45.8 billion with gross margins of 65-67%.
The Most Brutal High Beta Momentum Sell-Off Ever Recorded?
The market is experiencing what the author claims is the worst high beta momentum stock sell-off in history, surpassing the Great Financial Crisis, tariff tantrum, COVID crash, and dot-com bubble. The sell-off began at the end of June and has persisted with relentless pressure across high beta and momentum stocks, with no single clear fundamental catalyst explaining its magnitude.
Why it matters: Contributing factors include the failed Iran deal, potential rate hikes, ongoing Iran conflict, and historically weak equity performance during presidential midterm cycles, though none alone account for the severity of the move.
TSMC Commits Additional $100 Billion to US Chip Manufacturing
TSMC has pledged another $100 billion to expand its chipmaking capacity in the United States. The investment marks a significant escalation in the Taiwanese company's US manufacturing footprint.
Why it matters: This move is seen as a major commitment to boosting domestic semiconductor production.
Stocks making midday moves include Manpower, Abbott, UnitedHealth, TSMC
CNBC reported on stocks making the biggest moves midday, including Manpower, Abbott, UnitedHealth, and TSMC. The report is sourced from an RSS feed and awaits further analysis on market impact.